Follow
Nathan Peiffer-Smadja
Nathan Peiffer-Smadja
Associate Professor, Université Paris Cité, Assistance Publique Hôpitaux de Paris
Verified email at aphp.fr
Title
Cited by
Cited by
Year
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
T Fiolet, Y Kherabi, CJ MacDonald, J Ghosn, N Peiffer-Smadja
Clinical Microbiology and Infection 28 (2), 202-221, 2022
10142022
Type 1 interferons as a potential treatment against COVID-19
E Sallard, FX Lescure, Y Yazdanpanah, F Mentre, N Peiffer-Smadja
Antiviral research 178, 104791, 2020
6262020
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
5372021
Machine learning for clinical decision support in infectious diseases: a narrative review of current applications
N Peiffer-Smadja, TM Rawson, R Ahmad, A Buchard, P Georgiou, ...
Clinical Microbiology and Infection 26 (5), 584-595, 2020
4392020
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled …
F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ...
The Lancet infectious diseases 22 (2), 209-221, 2022
3932022
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
3852021
Open science saves lives: lessons from the COVID-19 pandemic
L Besançon, N Peiffer-Smadja, C Segalas, H Jiang, P Masuzzo, C Smout, ...
BMC Medical Research Methodology 21 (1), 117, 2021
3202021
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
T Fiolet, A Guihur, ME Rebeaud, M Mulot, N Peiffer-Smadja, ...
Clinical microbiology and infection 27 (1), 19-27, 2021
3102021
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ...
The Lancet 399 (10339), 1941-1953, 2022
3012022
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians
A Maury, A Lyoubi, N Peiffer-Smadja, T De Broucker, E Meppiel
Revue neurologique 177 (1-2), 51-64, 2021
2802021
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
Y Mahamat-Saleh, T Fiolet, ME Rebeaud, M Mulot, A Guihur, D El Fatouhi, ...
BMJ open 11 (10), e052777, 2021
2062021
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study
M Mailhe, AL Beaumont, M Thy, D Le Pluart, S Perrineau, ...
Clinical Microbiology and Infection 29 (2), 233-239, 2023
2002023
Neurologic manifestations associated with COVID-19: a multicentre registry
E Meppiel, N Peiffer-Smadja, A Maury, I Bekri, C Delorme, V Desestret, ...
Clinical Microbiology and Infection 27 (3), 458-466, 2021
1752021
Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre
N Peiffer-Smadja, JC Lucet, G Bendjelloul, L Bouadma, S Gerard, ...
Clinical microbiology and infection 26 (6), 669-672, 2020
1662020
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ...
Proceedings of the National Academy of Sciences 119 (21), 2022
1642022
Omicron SARS-CoV-2 variant: What we know and what we don’t
VM Ferré, N Peiffer-Smadja, B Visseaux, D Descamps, J Ghosn, ...
Anaesthesia, critical care & pain medicine 41 (1), 100998, 2021
1472021
Review of trials currently testing treatment and prevention of COVID-19
PC Fragkou, D Belhadi, N Peiffer-Smadja, CD Moschopoulos, FX Lescure, ...
Clinical Microbiology and Infection 26 (8), 988-998, 2020
1222020
Assessment of air contamination by SARS-CoV-2 in hospital settings
G Birgand, N Peiffer-Smadja, S Fournier, S Kerneis, FX Lescure, JC Lucet
JAMA network open 3 (12), e2033232-e2033232, 2020
1182020
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?
N Peiffer-Smadja, S Dellière, C Rodriguez, G Birgand, FX Lescure, ...
Clinical Microbiology and Infection 26 (10), 1300-1309, 2020
1182020
An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations
E Charani, M Mendelson, SJC Pallett, R Ahmad, M Mpundu, O Mbamalu, ...
The Lancet Global Health 11 (3), e466-e474, 2023
1162023
The system can't perform the operation now. Try again later.
Articles 1–20